The ODBC Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The ODBC Market:
https://www.thebusinessresearchcompany.com/report/odbc-global-market-report
According to The Business Research Company’s ODBC Global Market Report 2024, The open database connectivity (ODBC) market size is expected to see rapid growth in the next few years. It will grow to $3.67 billion in 2028 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to increased cloud adoption, big data and analytics growth, internet of things integration, cybersecurity concerns, edge computing. Major trends in the forecast period include cloud integration, big data and analytics, integration with IoT, AI-driven ODBC optimization, hybrid and multi-cloud connectivity.
The increasing adoption of cloud-based services is expected to propel the growth of the ODBC market going forward. Cloud-based services refer to computing services delivered over the internet from remote servers rather than being hosted on local servers or personal computers. As more people working remotely, cloud services are required to offer a convenient and secure way to access work data and applications. Open database connectivity (ODBC) is used in cloud-based services to enable applications to connect to and interact with databases hosted in the cloud, allowing applications to leverage the benefits of cloud computing while maintaining a standardized and widely supported interface for databases. For instance, in September 2022, according to survey of 753 technical and business professionals by the AAG IT Support Service, a US-based digital transformation service provider, around 63% of respondents reported heavy usage of cloud services in 2022, marking an increase from 59% in 2021 and 53% in 2020. Therefore, the increasing adoption of cloud-based services is driving the growth of the ODBC market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13891&type=smp
The odbc market covered in this report is segmented –
1) By Operating System: Windows, macOS, Linux, Other Operating Systems
2) By Deployment: Cloud, On-Premise
3) By Application: Marketing And Collaboration, Big Data And NOSQL, Customer Relationship Management (CRM) And Enterprise Resource Planning (ERP), File And Application Programming Interface (API), Accounting, E-Commerce, Relational Database Management System (RDBMS)
4) By End-User: Manufacturing, Banking, Financial Services, And Insurance, Government, Information Technology and Telecommunication, Electronics, Healthcare, Automotive, Other End Users
Major companies operating in the ODBC market are focusing on developing innovative solutions such as open-source ODBC drivers to meet the growing demand for ODBC. These software components acts as a translator between the application and the DBMS, converting the application's requests into commands that the DBMS can understand and vice versa. For instance, in August 2023, Amazon Web Services Inc., a US-based cloud service solutions company, launched an open-source ODBC driver that provides a structured query language (SQL)-relational interface for developers and enables connectivity from various business intelligence (BI) tools. The driver allows applications such as excel, powerBI, and JMP to seamlessly integrate with Timestream's query engine, facilitating the analysis of large amounts of time-series data. This driver comes with detailed documentation for setting up access, installing the driver, configuring data source names, and connecting through a proxy.
The odbc market report table of contents includes:
1. Executive Summary
2.ODBC Market Characteristics
3.ODBC Market Trends And Strategies
4.ODBC Market analysis
5.ODBC Market Size And Growth
6. ODBC Segmentation
7.ODBC Regional And Country Analysis
.
.
.
27.ODBC Competitive Landscape And Company Profiles
28.ODBC Key Mergers And Acquisitions
29. ODBC Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Alphabet Inc
- Microsoft Corporation
- International Business Machines Corporation
- Oracle Corporation
- SAP SE
- SAS Institute Inc.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
QuickBooks ODBC driver helps different applications to communicate and exchange the data with each other.
Undergo the blog to know the steps to install it.
The dynamic nature of ODBC means that changes are automatically updated.
Not all Tally users are familiar with setting up ODBC connections and engaging an expert to set this up and normalize data exchange does help.
Specify data from external data sources and select the new database queries after which you choose the data source.
Switch to excel and you can view all the selected columns.
If a purchase bill is entered it enhances the inventory level and when a sales bill is issued the quantity is deducted from the inventory.
Then there are times when an external inventory package may be the first point of data collection such as through barcode scanners for incoming inventory.
ODBC is the abbreviation of Open Database Connectivity, which is a protocol that you use to connect the particular Microsoft Access Database with an outsourced data source like MS SQL Server.Read more - https://internet-blogs.com/how-to-open-odbc-data-source-administrator-on-windows-10/Office.com/setup,ODBC, ODBC Data Source Administrator, Windows 10
Microsoft SQL Express uses dynamic havens.
Confirm that the punter workstation can telnet this haven by using the haven number in the ODBC connection.
The haven used by SQL Runner may be closed on the Firewall.
Let’s look at how to fix sage error SQL state 08001.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
